What's New Digest - Sept 24, 2011

[Guest guest]

What's New Digest - Sept 24, 2011

News and Reports: www.lymphomation.org/current.htm

=== Survivorship

University of Michigan Health System: 10 ways to make better decisions

about cancer care -- how to improve communication about risk

Cure Magazine: Managing Cancer-Related Diarrhea

MD: How to ask for help when chronic pain or illness strikes

The Oncologist: Cancer Disparities in the Context of Medicaid Insurance

WSJ: Getting Lab Results Directly to Patients

On Healthy Survivorship: Give Food or Money? Discusses an interesting

financial aid site

Dr. Len's Cancer Blog: We Can Treat The Cancer, But Can We Care For The

Survivors?

===Outcome Reports & Background

Blood: Adult Burkitt leukemia and lymphoma

Ntl Elec Library for Medicines: Phase II/III study of R-CHOP-21 vs.

R-CHOP-14 for untreated indolent B-Cell NHL

Blood: How I treat patients with DLBCL

CA: Improving Outcomes for Patients with DLBCL

ls of Hematology: Phase II trial of rituximab plus CVP combination

chemotherapy for advanced stage marginal zone lymphoma as a first-line

therapy

Alimentary Pharmacology and Therapeutics: Common misconceptions in the

management of H. pylori-associated gastric MALT

The Lancet: CHOP-like therapy with or without rituximab in young patients

with good-prognosis DLBCL: 6-year results - (MInT) Group

BJH: Biweekly R-COMP-14 in elderly patients with poor-risk DLBCL and

moderate to high ‘life threat’ impact cardiopathy

Oncology Hematology: Peripheral T-cell lymphoma – Not otherwise specified

NCI: Scientists find approach to enhance and prolong immune attack against

tumor cells

The Lancet: Prevention of CNS relapse in diffuse large B-cell lymphoma

NCCN: Advances in CLL Therapy Offer Prolonged Survival; Toxicities Continue

to Plague Elderly Patients

PTCL - Leukemia: Allogeneic transplantation following a reduced-intensity

conditioning regimen in relapsed/refractory peripheral T-cell lymphomas:

long-term remissions and response to donor lymphocyte infusions support the

role of a graft-versus-lymphoma effect

HODGKIN'S--J Clin Oncol: Lymphocyte-Depleted Classical Hodgkin's Lymphoma:

A Comprehensive Analysis From the German Hodgkin Study Group.

HODGKIN'S-- Blood: Phase II study of PVAG in elderly patients with early

unfavorable or advanced stage Hodgkin lymphoma

FDA Approves Brentuximab Vedotin for Hodgkin and Anaplastic Large-Cell

Lymphoma

Science Daily: Costly Blood Clots More Common Than Expected Among Cancer

Patients

===Videos / Webcasts

Patient Power: Personalized Oncology- Where are we now?

==== Advocacy and Notices

LRF: North American Educational Forum on Lymphoma Sept 30-Oct 2 --an

excellent conference-- check it out

LRF: Philadelphia-Ask the Doctor: Updates on Lymphoma and Treatments

R. , MD Fox Chase Cancer Center 10/12/11

PAL:

Lymphoma Awareness Month Brochure - PDF

Medscape: Congress Urged To Renew Commitment to Cancer Research

USA Today: A life and death wait for cancer medications in short supply

===Clinical Trials

NCI: Which Study Results Are the Most Helpful in Making Cancer Care

Decisions? http://1.usa.gov/oG1QoN

===PAL Updates

Lookup Trials by Type & Treatment Status

===Food for Thought

MSNBC: Many stem cell 'therapies' offer heartbreak

Respectful Insolence: Quacks do better than medicine!

Medical News Today: When To Administer Food And Drugs Together

Examiner.com: Blood Cancer Research Is The Super Highway To Curing Cancer

Cure Magazine: Açaí Berry’s Effect on Cancer?

Cure Magazine: Supplement Research in Cancer Lacking

Cure Magazine: Supplements During Cancer: Help or Hype?

Scientific American: Drugs from the Crucible of Nature

===Technical ... Theory/Preclinical

Rockefeller University Press: Tumor environment keeps tumor-fighting T

cells away

's Hopkins: Protein 'switches' could turn cancer cells into tiny

chemotherapy factories

News and Reports: www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL

(requires facebook account)

Special Thanks is Due to Anjou!

PATIENTS (helping-to-make-progress) AGAINST LYMPHOMA

www.lymphomation.org